CONTINUOUS SUBCUTANEOUS ADMINISTRATION OF INTERFERON-ALPHA TO HEPATITIS C INFECTED PATIENTS

Methods and systems for treating Hepatitis C infections are provided. Typically the method comprises administering interferon-α to the patient subcutaneously using a continuous infusion apparatus, wherein this therapeutic regimen is sufficient to maintain circulating levels of interferon-α in the se...

Full description

Saved in:
Bibliographic Details
Main Authors VAN ANTWERP WILLIAM P, GROVENDER ERIC A, JANSSEN HARRY L. A, DE KNEGT ROBERT J
Format Patent
LanguageEnglish
Published 03.02.2011
Subjects
CHEMISTRY
DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY
DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROMTHE BODY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Methods and systems for treating Hepatitis C infections are provided. Typically the method comprises administering interferon-α to the patient subcutaneously using a continuous infusion apparatus, wherein this therapeutic regimen is sufficient to maintain circulating levels of interferon-α in the serum of the patient above a target concentration for a certain period of time.
Bibliography:Application Number: US20100848856